News | February 25, 2013

Durata Therapeutics Announces Preliminary, Topline Phase 3 Clinical Trial Results for Dalbavancin in the Treatment of ABSSSI DISCOVER 2 Study Meets Primary & Secondary Endpoints Conference Call and Webcast Today at 8:30 A.M. EST to Discuss Results CHICAGO, Feb....

News | February 25, 2013

ReShape Medical Completes Enrollment of Pivotal Clinical Trial for Weight Loss Device SAN CLEMENTE, CA – February 25, 2013 – ReShape Medical® Inc announced today that it has completed enrollment in the pivotal clinical trial for the ReShape Duo® Intragastric Balloon,...

News | February 27, 2013

AccessClosure, Inc. Launches MynxGrip™ Vascular Closure Device New Grip Technology™ Sealant Redefines Active Closure Mountain View, CA (February 27, 2012) – AccessClosure, Inc., the market leader in extravascular closure devices, announced today the FDA approval and...

News | March 5, 2013

Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology BOULDER, Colo. and SOUTH SAN FRANCISCO, Calif., March 5, 2013 /PRNewswire/ — Array BioPharma Inc. (NASDAQ: ARRY) and Global Blood Therapeutics today...

News | March 12, 2013

Direct Flow Medical® Transcatheter Aortic Valve System Demonstrates Excellent Six-Month Outcomes In Discover Trial Results Presented on Podium at American College of Cardiology Annual Meeting SAN FRANCISCO, Calif., March 12, 2013 – Direct Flow Medical®, Inc., a...